Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4451
Ternium
TX
$10.2B
| $179K | ﹤0.01% |
5,774
-3,913
| -40% | -$119K |
|
4452
Red Rock Resorts
RRR
$3.68B
| $178K | ﹤0.01% |
7,698
-362
| -4% | -$8.36K |
|
4453
PUT
Sysco
SYY
$40.4B
| $178K | ﹤0.01% |
3,300
+800
| +32% | +$41.6K |
|
|
NVRO
4454
DELISTED
NEVRO CORP.
NVRO
| $178K | ﹤0.01% |
1,967
-9,356
| -83% | -$801K |
|
|
CSGS
4455
DELISTED
CSG Systems International
CSGS
| $177K | ﹤0.01% |
4,409
-3,898
| -47% | -$154K |
|
4456
CALL
Myriad Genetics
MYGN
$304M
| $177K | ﹤0.01% |
4,900
-6,100
| -55% | -$174K |
|
4457
MYR Group
MYRG
$5.16B
| $177K | ﹤0.01% |
6,053
-3,371
| -36% | -$93.2K |
|
4458
PUT
PG&E
PCG
$37.4B
| $177K | ﹤0.01% |
+2,600
| New | +$178K |
|
4459
PUT
ResMed
RMD
$32.4B
| $177K | ﹤0.01% |
2,300
+1,100
| +92% | +$84.1K |
|
4460
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.45B
| $176K | ﹤0.01% |
1,650
| – | – |
|
4461
CALL
Kimco Realty
KIM
$16.4B
| $176K | ﹤0.01% |
9,000
+2,300
| +34% | +$45.1K |
|
4462
Lands' End
LE
$397M
| $176K | ﹤0.01% |
13,266
+11,249
| +558% | +$146K |
|
|
LORL
4463
DELISTED
Loral Space and Communications, Inc.
LORL
| $176K | ﹤0.01% |
3,546
+2,105
| +146% | +$94.6K |
|
4464
AMERISAFE
AMSF
$551M
| $175K | ﹤0.01% |
3,007
-1,752
| -37% | -$98.3K |
|
4465
Baytex Energy
BTE
$2.93B
| $175K | ﹤0.01% |
58,019
| – | – |
|
4466
Sonic Automotive
SAH
$2.68B
| $175K | ﹤0.01% |
8,588
-58,578
| -87% | -$1.07M |
|
4467
Trustmark
TRMK
$2.79B
| $175K | ﹤0.01% |
5,283
+555
| +12% | +$17.3K |
|
4468
Unisys
UIS
$210M
| $175K | ﹤0.01% |
20,611
-101,937
| -83% | -$987K |
|
|
EGN
4469
PUT
DELISTED
Energen
EGN
| $175K | ﹤0.01% |
3,200
+2,500
| +357% | +$127K |
|
4470
CALL
Armstrong World Industries
AWI
$7.78B
| $174K | ﹤0.01% |
3,400
+1,700
| +100% | +$80K |
|
4471
CEVA Inc
CEVA
$992M
| $174K | ﹤0.01% |
4,059
-3,021
| -43% | -$130K |
|
4472
Colliers International
CIGI
$5.05B
| $174K | ﹤0.01% |
3,500
-600
| -15% | -$31.2K |
|
4473
CALL
Radian Group
RDN
$4.82B
| $174K | ﹤0.01% |
9,300
-7,100
| -43% | -$123K |
|
4474
Vera Bradley
VRA
$96.1M
| $174K | ﹤0.01% |
19,773
+17,334
| +711% | +$162K |
|
4475
Vanguard Total International Stock ETF
VXUS
$158B
| $174K | ﹤0.01% |
3,177
-2,097
| -40% | -$113K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.